New breath for rotavirus vaccines

Drug Discovery Today: Therapeutic Strategies

Volumn 3, Issue 2, 2006, Pages 159-165

  Parashar, Umesh D ^a   Bresee, Joseph S ^a   Widdowson, Marc Alain ^a   Gentsch, Jon R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE ROTAVIRUS VACCINE; LANZHOU LAMB ROTAVIRUS VACCINE; PLACEBO; ROTAVIRUS VACCINE; SIMIAN ROTAVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

CHILDHOOD DISEASE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; GASTROENTERITIS; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INTUSSUSCEPTION; LICENSING; REVIEW; ROTAVIRUS;

EID: 33746810982     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2006.06.005     Document Type: Review

References (35)

1. Parashar U.D., et al. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 9 (2003) 565-572
2. Parashar U.D., et al. Rotavirus in severe childhood diarrhea. Emerg. Infect. Dis. 12 (2006) 304-306
3. Kilgore P.E., et al. Trends of diarrheal disease-associated mortality in US children, 1968 through 1991. JAMA 274 (1995) 1143-1148
4. Parashar U.D. et al. Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J. Infect. Dis. 77, 13-17
5. Tucker A.W., et al. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 279 (1998) 1371-1376
6. Parashar U.D. Rotavirus. Emerg. Infect. Dis. 4 (1998) 562-570
7. Velazquez F.R., et al. Rotavirus infection in infants as protection against subsequent infections. N. Eng. J. Med. 335 (1996) 1022-1028
8. Gentsch J.R., et al. Review of G and P typing results from a global collection of strains: implications for vaccine development. J. Infect. Dis. 174 (1996) S30-S36
9. Gentsch J.R., et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J. Infect. Dis. 192 (2005) S146-S159
10. Ward R.L., et al. Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. J. Infect. Dis. 176 (1997) 570-577
11. Jiang B., et al. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin. Infect. Dis. 34 (2002) 1351-1361
12. Green K.Y., et al. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development. J. Infect. Dis. 161 (1990) 667-669
13. Vesikari T., et al. Protection of infants against rotavirus diarrhea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1 (1984) 977-981
14. Clark H.F., et al. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J. Infect. Dis. 158 (1988) 570-587
15. De Mol P., et al. Failure of live, attenuated oral rotavirus vaccine (letter). Lancet 2 (1986) 108
16. Hanlon P., et al. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1 (1987) 1342-1345
17. Lanata C.F., et al. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J. Infect. Dis. 159 (1989) 452-459
18. Georges-Courbot M.C., et al. Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res. Virol. 142 (1991) 405-411
19. Vesikari T., et al. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. J. Infect. Dis. 153 (1986) 832-839
20. Christy C., et al. Field trial of rhesus rotavirus vaccine in infants. Pediatr. Infect. Dis. J. 7 (1988) 645-650
21. Midthun K., et al. Reassortant rotaviruses as potential live rotavirus vaccine candidates. J. Virol. 53 (1985) 949-954
22. Kapikian A.Z., et al. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J. Infect. Dis. 174 (1996) S65-S72
23. CDC. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Morb. Mortal Wkly. Rep. 48 (1999) 1-20
24. Rennels M.B., et al. Lack of an apparent association between intussusception and wild or vaccine rotavirus infection. Pediatr. Infect. Dis. J. 17 (1998) 924-925
25. Murphy T.V., et al. Intussusception among infants given an oral rotavirus vaccine. N. Engl. J. Med. 344 (2001) 564-572
26. Heaton P.M., et al. Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis. J. Infect. Dis. 192 (2006) S17-S21
27. Vesikari T., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 354 (2006) 23-33
28. Kapikian A.Z., et al. A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. J. Infect. Dis. 192 (2005) S22-S29
29. De Vos B., et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 23 (2004) S179-S182
30. Phua K.B., et al. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. J. Infect. Dis. 192 (2005) S6-S16
31. Salinas B., et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr. Infect. Dis. J. 24 (2005) 807-816
32. Ruiz-Palacios G.M., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 354 (2006) 11-22
33. Glass R.I., et al. Development of candidate rotavirus vaccines derived from neonatal strains in India. J. Infect. Dis. 192 (2005) S30-S35
34. Barnes G.L., et al. Early phase II trial of human rotavirus vaccine candidate RV3. Vaccine 20 (2002) 2950-2956
35. Glass R.I., et al. The promise of new rotavirus vaccines. N. Engl. J. Med. 354 (2006) 75-77